{"id":3977,"date":"2017-09-23T17:28:08","date_gmt":"2017-09-23T17:28:08","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=3977"},"modified":"2017-09-26T04:32:30","modified_gmt":"2017-09-26T04:32:30","slug":"historia-y-futuro-de-terapia-t-car","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2017\/09\/23\/historia-y-futuro-de-terapia-t-car\/","title":{"rendered":"Historia y futuro de terapia T-CAR"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2016\/06\/2016-06-12-NEJM.jpg\"><img loading=\"lazy\" class=\"alignleft wp-image-3132 size-full\" style=\"border-width: 1px;margin: 5px\" title=\"(c) N Eng J Med 2017\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2016\/06\/2016-06-12-NEJM.jpg\" alt=\"2016 06 12 - NEJM\" width=\"85\" height=\"65\" \/><\/a>La modificaci\u00f3n gen\u00e9tica de linfocitos T aut\u00f3logos para dirigir su respuesta hacia tumores malignos, recientemente aprobada por la <a title=\"Sitio de FDA\" href=\"http:\/\/www.fda.gov\/\" target=\"_blank\">FDA<\/a> para el tratamiento de un grupo de enfermos con <a title=\"Informaci\u00f3n sobre la enfermedad en OMIM\" href=\"http:\/\/omim.org\/entry\/613065\" target=\"_blank\">leucemia linfobl\u00e1stica aguda<\/a>, tiene potencialidades para extenderse a muchas otras enfermedades, incluidos los tumores s\u00f3lidos. As\u00ed se declara en Rosenbaum L. <a title=\"Texto completo en ingl\u00e9s\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp1711886?query=TOC\" target=\"_blank\">Tragedy, Perseverance, and Chance \u2014 The Story of CAR-T Therapy<\/a>. N Eng J Med 2017; DOI: 10.1056\/NEJMp1711886.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La modificaci\u00f3n gen\u00e9tica de linfocitos T aut\u00f3logos para dirigir su respuesta hacia tumores malignos, recientemente aprobada por la FDA para el tratamiento de un grupo de enfermos con leucemia linfobl\u00e1stica aguda, tiene potencialidades para extenderse a muchas otras enfermedades, incluidos los tumores s\u00f3lidos. As\u00ed se declara en Rosenbaum L. Tragedy, Perseverance, and Chance \u2014 The [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11,23,32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3977"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=3977"}],"version-history":[{"count":3,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3977\/revisions"}],"predecessor-version":[{"id":3997,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3977\/revisions\/3997"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=3977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=3977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=3977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}